NEW HAVEN, Conn., Nov. 26, 2007 (PRIME NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (NasdaqGM:ACHN - News), a leader in the discovery and development of small molecule drugs to combat the most challenging infectious diseases, today announced the appointment of Dr. Elizabeth A. Olek as vice president and chief medical officer. Dr. Olek joins Achillion as a member of the executive management team and will lead the clinical development of Achillion's product development candidates. Dr. Olek joins Achillion from Novartis Pharmaceuticals Corporation.
